Document is current

Any future updates will be listed below

291 Dual-specific antibodies blocking both PD-L1 and PD-L2 engagement of PD-1 restore anti-tumor immunity

Crossref DOI link: https://doi.org/10.1136/jitc-2021-SITC2021.291

Published Online: 2021-11-10

Published Print: 2021-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark